Opus Capital Group, LLC Astrazeneca PLC Transaction History

Opus Capital Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 04, 2019	SELL	$40.12 - $45.47 $285,052 - $323,064	-7,105 Closed	0 $0
Q1 2019 Apr 30, 2019	SELL	$35.49 - $43.02 $19,342 - $23,445	-545 Reduced 7.12%	7,105 $287,000
Q3 2018 Nov 06, 2018	SELL	$34.76 - $39.72 $121,660 - $139,020	-3,500 Reduced 31.39%	7,650 $303,000
Q3 2017 Nov 07, 2017	BUY	$28.96 - $34.0 $322,904 - $379,100	11,150	11,150 $378,000

1,343

492M

4.99M

3.18M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $220B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Opus Capital Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Opus Capital Group, LLC with notifications on news.